TRULICITY 1.5 MG pen

Trulicity 1.5 mg Pre-Filled Pen 0.5 ml 

Trulicity 1.5 mg Pre-Filled Pen 0.5 ml is primarily used to treat type 2 diabetes mellitus. The metabolic condition diabetes mellitus is characterized by unusually high blood sugar levels. It occurs when insulin (a hormone produced by the beta cells of the pancreas) is unable to convert glucose into energy (insulin resistance) or when the pancreas produces inadequate or no insulin.

The Trulicity 1.5 mg Pre-Filled Pen contains Dulaglutide, a “incretin mimetic” drug. Dulaglutide functions by increasing pancreatic insulin production during times of high blood sugar (after meals) and decreasing the amount of sugar produced by the liver. In addition, Trulicity 1.5 mg Pre-Filled Pen 0.5 ml minimizes the risk of cardiovascular disease in type 2 diabetic patients.

Your doctor will select the dose and duration of Trulicity 1.5 mg Pre-Filled Pen 0.5 ml based on your medical situation. Frequent adverse effects of Trulicity 1.5 mg Pre-Filled Pen 0.5 ml include nausea, vomiting, diarrhoea, diminished appetite, stomach pain, constipation, and exhaustion. These negative consequences are not universal and vary from person to person. Consult your physician if you have uncontrollable side effects.

If you have a family history of heart, kidney, or liver disease, inform your doctor prior to initiating Trulicity 1.5 mg Pre-Filled Pen 0.5 ml. To prevent hypoglycemia when using Trulicity 1.5 mg Pre-Filled Pen 0.5 ml, it is advised to minimize alcohol consumption. Before using Trulicity 1.5 mg Pre-Filled Pen 0.5 ml if you are pregnant or breastfeeding, consult your doctor. The Trulicity 1.5 mg Pre-Filled Pen 0.5 ml may produce weariness; thus, do not drive or operate heavy machinery until your condition has improved. Children and teenagers less than 18 years old should not use the Trulicity 1.5 mg Pre-Filled Pen 0.5 ml.

Type 2 Diabetes mellitus 0.5 ml Trulicity 1.5 mg Pre-Filled Pen

Medicinal Advantages

For the treatment of type 2 diabetes, the Trulicity 1.5 mg Pre-Filled Pen 0.5 ml is utilized. It is an incretin mimic that functions similarly to Incretin, a naturally occurring hormone (a metabolic hormone that stimulates a decrease in blood glucose levels). It functions by enhancing pancreatic insulin secretion during periods of increased blood sugar (after meals) and decreasing hepatic sugar production. In addition, the Trulicity 1.5 mg Pre-Filled Pen 0.5 ml reduces the risk of serious heart problems such as heart attack or stroke in those with type 2 diabetes and cardiovascular disease. Trulicity 1.5 mg Pre-Filled Pen 0.5 ml may be prescribed alone or in conjunction with other medications to manage blood glucose levels.

Use Instructions

Subcutaneously in the abdomen, the thigh, or the upper arm. Your doctor or nurse will provide you with instructions on how to administer the injection. The dosage will be determined by your physician based on the severity of your disease and your tolerance. Your doctor may start with a low dose and progressively raise it until the appropriate level of blood glucose control is achieved.

Storage Avoid direct sunlight and store in a cool, dry spot.

Trulicity 1.5 mg Pre-Filled Pen 0.5 ml Adverse Reactions

Nausea

Vomiting

Diarrhea

Appetite reduction

Constipation Stomach discomfort

Tired

Adverse Drug Reactions

Inform your doctor if you have heart, kidney, or liver disease, pancreatitis (inflammation of the pancreas), stomach diseases such as acid reflux or gastroparesis (slow gastric emptying), hypoglycemia (low blood sugar), diabetic retinopathy, or type 1 diabetes before commencing Dulaglutide. Dulaglutide is contraindicated in patients with type 2 multiple endocrine neoplasia, diabetic ketoacidosis (in which the body produces too many blood acids (ketones)), and a personal or family history of thyroid cancer. It is not permissible to share an injectable pen, cartridge, or syringe, even if the needle has been replaced. Alcohol should be avoided when taking Dulaglutide to prevent dangerously low blood sugar levels. Before beginning this medication, women who are pregnant or breastfeeding should visit their physician. Dulaglutide may cause weariness; do not drive or operate heavy machinery until your condition has improved. Dulaglutide is contraindicated for use in children and adolescents younger than 18 years of age.

Interactions Between Drugs

Dulaglutide may interact with insulin glargine, hormone replacement treatment (levothyroxine), hypertension drugs (propranolol, metoprolol), and glaucoma eye drops (timolol).

Due to its effect on glucose levels, alcohol consumption should be restricted. Avoid fatty foods and consume more healthful carbohydrates.

Inform your doctor if you have a history of adverse drug reactions, heart, kidney, or liver disease, pancreatitis, gastroparesis, reflux, or hypoglycemia before taking Dulaglutide. Patients with type 2 multiple endocrine neoplasia, diabetic ketoacidosis, or a personal or family history of thyroid cancer should not take dulaglutide.

Safety Recommendations

ALCOHOL

It is advised to limit alcohol consumption, since it may intensify bad effects and increase the likelihood of developing hypoglycemia.

PREGNANCY

If you are pregnant or expecting to become pregnant, consult your doctor before beginning Dulaglutide treatment. Your doctor will only prescribe medication if the possible benefit outweighs the potential risk.

BREAST FEEDING

Insufficient data exist on the effect of Dulaglutide on breastfeeding. Before starting Dulaglutide, it is important to get medical advice if you are breastfeeding.

DRIVING

Avoid driving or operating heavy machinery if you are experiencing signs of low blood sugar.

LIVER

Inform your doctor if you have a history of liver disease or hepatic impairment prior to receiving Dulaglutide.

KIDNEY

Inform your doctor if you have a family history of kidney issues before taking Dulaglutide.

No.

Advice on Diet and Lifestyle

Maintain a high-fiber diet consisting primarily of fruits, vegetables, and whole grains to help regulate blood glucose levels.

Consume food at consistent intervals.

To keep your heart healthy, you should maintain a healthy weight and engage in regular exercise.

Follow your physician’s recommendations for identifying and treating early symptoms of high/low blood sugar.

Simple modifications in lifestyle can aid in the management of gastrointestinal side effects. These include consuming less sugar and fat, as well as avoiding carbonated beverages and meals that cause gas.

Special Guidance

It is essential that you frequently monitor your blood sugar levels.

Additional Information: This item cannot be returned.

Concern for Patients

Diabetes mellitus is a metabolic condition characterized by increased blood sugar levels. Diabetes mellitus is also known as adult-onset diabetes mellitus. It occurs when insulin is inadequate at breaking down glucose to produce energy (insulin resistance) or when the pancreas (an organ behind the stomach) produces insufficient or no insulin. Despite the fact that this condition is more common in those over the age of 40, it can also occur in youth, depending on the risk factors. Oral glucose-lowering medicines and insulin injections are used to treat diabetes.

FAQs

The Trulicity 1.5 mg Pre-Filled Pen 0.5 ml contains Dulaglutide, which stimulates the pancreas to create insulin when blood glucose levels are too high following meals. Therefore, Dulaglutide aids to the decrease of blood sugar levels in type 2 diabetic patients.

Dulaglutide may cause hypoglycemia, which can result in feelings of hunger, dizziness, irritability, confusion, anxiety, or trembling. It is therefore advised to take Dulaglutide with food. To swiftly treat hypoglycemia, it is advised to take sugar sources with a rapid onset of action, such as fruit juices, hard candies, raisins, and regular cola.

Use only injectable solutions that are clear, colorless, and devoid of particles. Administer the injection subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Your doctor or nurse will provide you with instructions on how to administer the injection. You can take Dulaglutide with or without food. To avoid hypoglycemia and gastrointestinal side effects, it is recommended that the injection be administered following a meal. It is not permissible to share an injectable pen, cartridge, or syringe, even if the needle has been replaced.

Dulaglutide may be used alone or in conjunction with other medications to regulate blood sugar levels. Dulaglutide should only be used with other anti-diabetic drugs if prescribed by a physician. Dulaglutide and insulin injections must be administered separately if insulin is also being taken. Please do not mix them. Both injections may be done at the same site on the body, but the injection sites should not be contiguous.

Immediately administer the missed dose. If the next dose is near, however, you should omit the missed dose and resume your regular dosing schedule. Contrary to popular perception, the dose should not be doubled.

Keep unused Dulaglutide refrigerated between 2°C and 8°C and out of direct sunlight. Dulaglutide may also be stored between 15°C and 30°C at room temperature for up to 14 days prior to administration. This medication should not be frozen. The frozen Trulicity 1.5 mg Pre-Filled Pen 0.5 ml should not be used.